Skip to main content

Amanda Van Swearingen

Research Program Leader, Sr
Medicine
232 Baker House, Trent Drive, Box #3381, Durham, NC 27710
20 Sydenham Road, Durham, NC 27713

Research Interests


Brain Metastases
Spine Metastases
Leptomeningeal Disease
Breast Cancer
Lung Cancer
Melanoma

Selected Grants


Breast Cancer Brain Metastases: Integrating Immunogenomic and Phenotypic Vulnerabilities to Improve Outcomes

ResearchProject Planner · Awarded by Department of Defense · 2025 - 2026

Ancestry-related RNA splicing and immune expression in metastatic breast cancer

ResearchResearch Associate · Awarded by Susan G. Komen Breast Cancer Foundation · 2022 - 2025

Existing Sample Review for nFerence Collaboration

ResearchResearch Program Leader · Awarded by nference, Inc. · 2022 - 2024

Immunotherapy to treat Triple Negative Breast Cancer Brain Metastases

ResearchResearch Associate · Awarded by University of North Carolina - Chapel Hill · 2019 - 2021

Gender Differences in Stimulant Action

ResearchResearch Assistant · Awarded by National Institutes of Health · 1998 - 2013

External Relationships


  • Abbott Laboratories
  • Cardinal Health, Inc.
  • Merck & Co. USA (not assoc'd with Merck KGaA)
  • NVIDIA CORPORATION

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.